KACVINSKA, Katarina, Veronika PAVLINAKOVA, Petr POLACEK, Lenka MICHLOVSKA, Veronika HEFKA BLAHNOVA, Eva FILOVA, Martin KNOZ, Břetislav LIPOVÝ, Jakub HOLOUBEK, Martin FALDYNA, Zdeněk PAVLOVSKÝ, Monika VICENOVA, Michaela CVANOVÁ, Jiří JARKOVSKÝ and Lucy VOJTOVA. Accelular nanofibrous bilayer scaffold intrapenetrated with polydopamine network and implemented into a full-thickness wound of a white-pig model affects inflammation and healing process. JOURNAL OF NANOBIOTECHNOLOGY. LONDON: BIOMED CENTRAL LTD, 2023, vol. 21, No 1, p. 1-24. ISSN 1477-3155. Available from: https://dx.doi.org/10.1186/s12951-023-01822-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Accelular nanofibrous bilayer scaffold intrapenetrated with polydopamine network and implemented into a full-thickness wound of a white-pig model affects inflammation and healing process
Authors KACVINSKA, Katarina (203 Czech Republic), Veronika PAVLINAKOVA (203 Czech Republic), Petr POLACEK (203 Czech Republic), Lenka MICHLOVSKA (203 Czech Republic), Veronika HEFKA BLAHNOVA (203 Czech Republic), Eva FILOVA (203 Czech Republic), Martin KNOZ (203 Czech Republic, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Martin FALDYNA (203 Czech Republic), Zdeněk PAVLOVSKÝ (203 Czech Republic, belonging to the institution), Monika VICENOVA (203 Czech Republic), Michaela CVANOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Lucy VOJTOVA (203 Czech Republic, guarantor).
Edition JOURNAL OF NANOBIOTECHNOLOGY, LONDON, BIOMED CENTRAL LTD, 2023, 1477-3155.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 10.200 in 2022
RIV identification code RIV/00216224:14110/23:00130597
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/s12951-023-01822-5
UT WoS 000945497200002
Keywords in English Bilayer; Chitosan; Collagen; Oxidized cellulose; Polydopamine; Wound healing
Tags 14110128, 14110229, 14110230, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 08:20.
Abstract
Treatment of complete loss of skin thickness requires expensive cellular materials and limited skin grafts used as temporary coverage. This paper presents an acellular bilayer scaffold modified with polydopamine (PDA), which is designed to mimic a missing dermis and a basement membrane (BM). The alternate dermis is made from freeze-dried collagen and chitosan (Coll/Chit) or collagen and a calcium salt of oxidized cellulose (Coll/CaOC). Alternate BM is made from electrospun gelatin (Gel), polycaprolactone (PCL), and CaOC. Morphological and mechanical analyzes have shown that PDA significantly improved the elasticity and strength of collagen microfibrils, which favorably affected swelling capacity and porosity. PDA significantly supported and maintained metabolic activity, proliferation, and viability of the murine fibroblast cell lines. The in vivo experiment carried out in a domestic Large white pig model resulted in the expression of pro-inflammatory cytokines in the first 1–2 weeks, giving the idea that PDA and/or CaOC trigger the early stages of inflammation. Otherwise, in later stages, PDA caused a reduction in inflammation with the expression of the anti-inflammatory molecule IL10 and the transforming growth factor β (TGFβ1), which could support the formation of fibroblasts. Similarities in treatment with native porcine skin suggested that the bilayer can be used as an implant for full-thickness skin wounds and thus eliminate the use of skin grafts.
Links
NU22-08-00454, research and development projectName: Biomimetický vícevrstevný buněčný nosič čtvrté generace pro jednokrokovou úplnou náhradu kůže: z laboratoře do klinické aplikace
Investor: Ministry of Health of the CR, Subprogram 1 - standard
90110, large research infrastructuresName: CzechNanoLab
PrintDisplayed: 10/7/2024 20:48